USFDA completes inspection at Indoco Remedies’ Clinical Research Organisation

18 Oct 2019 Evaluate

US Food and Drug Administration (USFDA) has successfully concluded inspection at Indoco Remedies’ Clinical Research Organisation, AnaCipher with zero 483s. The inspection was held from October 14, 2019 to October 18, 2019. The CRO - AnaCipher conducts Bio-Equivalence and Bio-Availability (BA/BE) studies at its facility in Hyderabad and is spread over an area of 30,000 sq. ft. with 98 beds.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

328.40 -1.75 (-0.53%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.